Smith & Nephew supports healthcare professionals in more than 100 countries in their daily efforts to improve the lives of their patients.
We do this by taking a pioneering approach to the design of our advanced medical products and services, by securing wider access to our diverse technologies for more customers globally, and by enabling better outcomes for patients and healthcare systems.
We have leadership positions in:
Orthopaedics Reconstruction - joint replacement systems for knees, hips and shoulders
Advanced Wound Management - wound care treatment and prevention products used to treat hard-to-heal wounds
Sports Medicine - minimally invasive surgery of the joint
Trauma & Extremities - products that help repair broken bones
We have around 16,000 employees around the world.
Annual sales in 2017 were almost $4.8 billion.
We are a constituent of the UK's FTSE100 and our shares are traded on the London Stock Exchange and through American Depository Receipts on the New York Stock Exchange (LSE: SN, NYSE: SNN).
Smith & Nephew has a strong foundation in the ANZ region, having been established in Australia in 1950 and New Zealand in 1953. We have five Australia state offices and three in New Zealand with our head office located in North Ryde, Sydney.